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Abstract
CD16+ monocytes, identified as a minor population of monocytes in human peripheral blood,
have been implicated in several inflammatory diseases, including rheumatoid arthritis (RA). Fractalkine
(FKN, CX3CL1), a member of the CX3 C subfamily, is induced by pro-inflammatory cytokines,
while a receptor for FKN, CX3CR1, is capable of mediating both leukocyte migration and firm
adhesion. Here, we investigated the role of FKN and CX3CR1 in activation of CD16+ mono-
cytes and their recruitment into synovial tissues in RA patients. High levels of soluble FKN were
detected in the synovial fluid and sera of RA patients. Circulating CD16+ monocytes showed
a higher level of CX3CR1 expression than CD16- monocytes in both RA patients and healthy
subjects. High level expression of CX3CR1 was also seen in CD16+ monocytes localized to the
lining layer in RA synovial tissue. In the in vitro culture experiments, IL-10 induced CX3CR1
expression on the surface of monocytes, and TNFalpha induced membrane-bound FKN as well as
soluble FKN expression in synovial fibroblasts. Moreover, soluble FKN was capable of inducing
IL-1beta and IL-6 by activated monocytes. These results suggest that FKN might preferentially
mediate migration and recruitment of CD16+ monocytes, and might contribute to synovial tissue
inflammation.
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ractalkine (FKN,  CX3CL1),  a member of the 
CX3 C subfamily,  is a unique chemokine in 
which the ﬁ rst 2 conserved cysteine residues are 
separated by 3 non-conserved amino acids.  Unlike 
other chemokines,  FKN exists in 2 forms : a mem-
brane-anchored and a soluble form.  Soluble FKN 
acts as a chemoattractant,  whereas the membrane-
anchored molecule functions as an adhesion molecule. 
The membrane-anchored form of FKN comprises a 
chemokine domain tethered to the cell surface via a 
heavily glycosylated mucin-like stalk,  followed by a 
single transmembrane and a single cytoplasmic 
domain [1,  2].  The full-length molecule can be 
cleaved from the cell membrane by tumor necrosis 
factor (TNF) ｸ-converting enzyme (TACE),  a mem-
ber of the ADAM (disintegrin and metalloprotease) 
family,  and ADAM10,  to produce a soluble form 
comprising the chemokine domain and most of the 
stalk region [1].  FKN is found to be expressed on 
the surface of endothelial cells,  epithelial cells [3,  4], 
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dendritic cells [5,  6] and neurons [7] and is induced 
by pro-inﬂ ammatory cytokines such as interleukin 
(IL)-1 and TNFｸ [8,  9].  The receptor for FKN, 
CX3CR1,  is capable of mediating both leukocyte 
migration and ﬁ rm adhesion.  CX3CR1 is expressed 
on a number of leukocytes,  including monocytes,  T 
cell subsets,  and NK cells [10,  11].
　　Rheumatoid arthritis (RA) is a chronic disorder of 
unknown etiology that leads to progressive joint 
destruction.  RA is characterized by a massive syno-
vial inﬁ ltration of lymphocytes and macrophages [12], 
and extensive proliferation of ﬁ broblast-like synovio-
cytes [13].  In association with joint inﬂ ammation, 
blood monocytes are functionally activated in RA [14]. 
We previously demonstrated that CD16＋ monocytes 
with low CD14 expression are increased according to 
disease activity [15].  CD14＋/CD16＋ cells were 
deﬁ ned as a subset of monocytes that accounts for ～
10ｵ of all peripheral monocytes in healthy individu-
als,  and an increase in these cells has been demon-
strated in other inﬂ ammatory conditions,  including 
sepsis,  human immunodeﬁ ciency virus 1 infection and 
cancer [16].  Compared with CD14＋＋/CD16－ con-
ventional monocytes,  CD16＋ monocytes express 
higher levels of major histocompatibility complex 
(MHC) class II antigens,  adhesion molecules,  chemo-
kine receptors,  and proinﬂ ammatory cytokines such 
as TNFｸ,  but lower levels of the anti-inﬂ ammatory 
cytokine,  i.e.,  IL-10 [15,  17].  Cytokines such as 
macrophage colony-stimulating factor (M-CSF), 
IL-10,  and transforming growth factor ｹ (TGFｹ) 
have been implicated in induction of cell surface 
CD16 [17],  and a spillover of these cytokines from 
the inﬂ amed joints may be important in the pathogen-
esis of RA [15].
　　Interactions of FKN and CX3CR1 might contrib-
ute to the accumulation of CX3CR1＋ T cells express-
ing type 1 cytokines and possessing cytotoxic gran-
ules in the RA synovium [18].  Such a scenario could 
be applicable to the mechanism of macrophage inﬁ l-
tration into the synovial tissues,  and we hypothesized 
that the FKN/CX3CR1 pathway might mediate the 
recruitment of CD16 monocytes in RA patients.  In 
the current study,  we investigated the expressions of 
FKN and its receptor CX3CR1 on the circulating 
CD16＋ monocytes and inﬁ ltrated CD16＋ macro-
phages in RA patients.  Furthermore,  we examined 
the induction of FKN and CX3CR1 expression by 
various pro-inﬂ ammatory cytokines.
Patients and Methods
　　Patients and samples.　 Subjects consisted of 
22 patients with RA (19 women and 3 men ; mean±
SD age,  62.4 ± 2.5 years),  16 patients with osteoar-
thritis (OA) (11 women and 5 men ; mean ± SD age, 
66.3 ± 1.5 years),  and 12 healthy age-matched volun-
teers (8 women and 4 men ; 50.9 ± 9.3 years) who 
served as controls.  The presence of RA was diag-
nosed according to the revised 1987 criteria of the 
American College of Rheumatology (formerly,  the 
American Rheumatism Association) [19],  and all 
patients provided written informed consent to partici-
pate in the study.  Paired samples of serum and syno-
vial ﬂ uid were obtained from the RA and OA 
patients.  Most RA patients received nonsteroidal 
anti-inﬂ ammatory drugs,  prednisolone (≦ 7.5 mg/
day),  and disease-modifying antirheumatic drugs. 
Clinical parameters in the study RA patients were as 
follows (mean ± SD) : serum C-reactive protein level, 
45.7 ± 10.8 mg/liter ; IgM class rheumatoid factor 
(RF) titer,  129 ± 38.9 units/ml.  Synovial tissue 
samples were obtained from RA patients at the time 
of surgical treatment.
　　Two-color immunoﬂ uorescence labeling.
Cryostat sections (4 ｻm) from RA synovial tissues 
were ﬁ xed in acetone,  and blocked with 10ｵ goat 
serum for 30 min.  Double immunoﬂ uorescence was 
performed by serially incubating sections with 
10 μg/ml of mouse IgG1 anti-CD16 monoclonal anti-
body (mAb) (Sigma,  St.  Louis,  MO,  USA),  rat 
IgG2b anti-CX3CR1 mAb (2A9-1 ; Medical & 
Biological Laboratories,  Nagoya,  Japan),  and iso-
type control mAbs at 4 °C overnight,  followed by 
incubation with ﬂ uorescein isothiocyanate (FITC)-
conjugated anti-mouse IgG1 mAb (AbD Serotec, 
Oxford,  UK) and Texas red-conjugated goat anti-rat 
IgG mAb (Rockland,  Philadelphia,  PA,  USA) for 
30 min at room temperature.  Double immunoﬂ uores-
cence of sections was examined with an LSM510 
inverted confocal laser-scanning microscope (Carl 
Zeiss,  Jena,  Germany).
　　Flow cytometry.　 Peripheral blood mononu-
clear cells (PBMC) from patients with RA and 
healthy controls (HC) were prepared from heparin-
ized blood samples by centrifugation over Ficoll-
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Hypaque density gradients (Pharmacia,  Uppsala, 
Sweden).  Cells were washed well with RPMI-1640 
medium (Life Technologies,  Gaithersburg,  MD, 
USA),  and were resuspended in phosphate buﬀ ered 
saline (PBS) with 1ｵ heat-inactivated fetal calf 
serum (FCS ; Life Technologies).  Cell surface 
expressions of CD14,  CD16,  and CX3CR1 were 
analyzed by cell surface staining and ﬂ ow cytometric 
analysis,  as described previously [15].  PBMC sus-
pensions were incubated with FITC-conjugated anti-
CX3CR1 mAb (2A9-1 ; Medical & Biological 
Laboratories),  or isotype-matched control mAb 
(Immunotech,  Marseille,  France).  Cells were washed 
and then incubated with phycoerythrin (PE)-
conjugated anti-CD14 mAb (61D3 ; eBioscience,  San 
Diego,  CA,  USA) and phycoerythrin-cyanin 5.1 (PC5) 
-conjugated anti-CD16 mAb (3G8 ; Immunotech). 
After washing,  cells were resuspended in 1ｵ FCS/
PBS.  Analysis was performed on a FACScan ﬂ ow 
cytometer (Becton Dickinson,  Franklin Lakes,  NJ, 
USA).
　　Isolation and culture of blood monocytes.
PBMC from HC were resuspended at a density of 
5 × 106 cells in culture medium (RPMI 1640 medium 
supplemented with 25 mM HEPES,  2 mM 
L-glutamine,  2ｵ nonessential amino acids,  100 
units/ml penicillin,  and 100 μg/ml streptomycin) 
with 10ｵ FCS.  The cell suspensions were incubated 
in 6-well plates (Corning,  Corning,  NY,  USA) at 
37 °C for 2 h in a humidiﬁ ed atmosphere containing 5
ｵ CO2.  After nonadherent cells were removed, 
adherent monocytes were gently harvested using a 
rubber scraper.  The purity was conﬁ rmed to be 
＞ 95ｵ CD14＋ by ﬂ ow cytometry.  The monocyte 
suspensions were stimulated in fresh 10ｵ FCS/cul-
ture medium with 10 ng/ml of TNFｸ (Dainippon, 
Osaka,  Japan),  IL-1ｹ (Otsuka,  Tokushima,  Japan), 
interferon ｺ (IFNｺ) (PeproTech,  London,  UK), 
LPS (Escherichia coli 055 : B5 ; Sigma) and IL-10 
(Becton Dickinson).  Total RNA was isolated from 
monocytes collected after 3 h of culture.
　　To examine the eﬀ ects of FKN on IL-1ｹ and IL-6 
production,  monocytes were treated for 3 h with 
10 mM Dibutyryl-cAMP(DBcAMP) (BIOMOL, 
Plymouth Meeting,  PA,  USA) prior to addition of 
recombinant human FKN (R & D systems,  Minnea-
polis,  MN,  USA).  The culture supernatants were 
harvested after 36 h of FKN treatment and measured 
for IL-1ｹ and IL-6 concentrations.
　　Isolation and culture of synovial ﬁ broblasts.
Fresh synovial tissues from RA patients were minced 
with scissors and digested for 1 h with collagenase 
(WAKO,  Osaka,  Japan) and DNase (Sigma) in 
RPMI-1640 at 37 °C.  After removing tissue debris 
through a cell strainer,  the cells were washed twice 
with medium.  The resultant single cell suspensions 
were dispensed into the wells of a 24-well microtiter 
plate (Costar,  Cambridge,  MA,  USA) at a density 
of 2 × 106/ml in 2 ml of Dulbecco’s modiﬁ ed Eagle’s 
medium (DMEM) (Life Technologies) supplemented 
with 10ｵ FCS,  25 mM of HEPES (Life 
Technologies),  100 IU/ml of penicillin,  and 100 μg/
ml of streptomycin.  The plates were incubated at 
37 °C in a humidiﬁ ed atmosphere containing 5ｵ CO2. 
The culture supernatants were harvested 72 h later 
and stored at － 30 °C until chemokine assay.  For 
the detection of chemokine mRNA expression,  total 
RNA was isolated from fresh synovial tissue cells. 
Synovial ﬁ broblasts were obtained by allowing syno-
vial tissue cells to adhere to tissue culture plates, 
followed by removal of nonadherent cells,  as 
described previously [20].  These cells were split 
weekly,  once primary cultures had reached conﬂ u-
ence,  and experiments were performed using synovial 
ﬁ broblast cell lines after the third or fourth passage. 
The resultant cells were morphologically homoge-
neous ﬁ broblast-like cells that had typical bipolar 
conﬁ guration under inverse microscopy,  and there 
were ＜ 2ｵ of contaminating lymphocytes or macro-
phages,  as assessed by ﬂ ow cytometry and staining 
with antibodies against CD3,  CD14,  and CD19 
(Becton Dickinson).  Synovial ﬁ broblasts were stimu-
lated in fresh 10ｵ FCS/culture medium with 10 ng/
ml of TNFｸ,  IL-1ｹ,  IFNｺ and LPS.  Total RNA 
was isolated from synovial ﬁ broblasts collected after 
3 h of culture.
　　In a similar manner,  synovial ﬁ broblasts were 
stimulated with 10 ng/ml of TNFｸ,  IL-1ｹ,  IFNｺ 
and LPS for 24 h.  The culture supernatants and cell 
lysates were then treated with passive lysis buﬀ er 
(Promega,  Madison,  WI,  USA),  collected,  and sub-
jected to measurement of membrane-anchored and 
soluble FKN concentrations.
　　Isolation of mRNA and real-time polymerase 
chain reaction (PCR).　 Total cellular RNA was 
extracted from monocytes and synovial ﬁ broblasts 
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using an RNA isolation kit (RNeasy Mini kit ; Qiagen, 
Valencia,  CA,  USA).  cDNA was synthesized from 
total RNA with Molony murine leukemia virus 
reverse transcriptase (US Biochemical,  Cleveland, 
OH,  USA) and oligo-(dT)15 primers (Promega).  Real-
time PCR was performed with a LightCycler 
Instrument (Roche Diagnostics,  Penzberg,  Germany) 
in glass capillaries.
　　The cDNA samples were denatured at 95 °C for 
10 min,  then ampliﬁ ed for 40ﾝ50 cycles of 95 °C for 
10 sec,  65 °C for 15 sec,  and 72 °C for 10 sec (ｹ
-actin and CX3CR1) or 95 °C for 10 sec,  70 °C for 
15 sec,  and 72 °C for 10 sec (FKN).  Ampliﬁ cation 
curves of the ﬂ uorescence values versus cycle num-
ber were obtained,  and a melting curve analysis was 
performed.  The levels of FKN and CX3CR1 expres-
sion were determined by normalizing relative to ｹ
-actin expression.  The forward and reverse primers 
were as follows : for ｹ-actin,  5’-GCATGGGT
CAGAAGGATTCCTATG-3’ and 5’-CATCTCCA
TCACTCGTGTGGTAAG-3’ ; for FKN,  5’-TTAT
CACTCCTGTCCCTGACGC-3’ and 5’-GCCATCTC
TCCTGCCATCTTTC-3’ ; for CX3CR1,  5’-TTGC
CTGAATCCTCTCATCTATGC-3’ and 5’-CATC
TCCATCACTCGTGTGGTAAG-3’.
　　Immunoassays for cytokines.　 The sera and 
synovial ﬂ uid were diluted 1 : 10 with PBS and sub-
jected to quantitative sandwich enzyme-linked immu-
nosorbent assay (ELISA).  Concentrations of FKN, 
IL-1ｹ,  and IL-6 were measured in duplicate using 
cytokine-speciﬁ c capture with biotinylated detection 
mAb and recombinant cytokine proteins,  FKN,  IL-1ｹ, 
and IL-6 (Becton Dickinson),  according to the manu-
facturer’s instructions.  The detection limits were 
20 pg/ml for IL-1ｹ and IL-6,  and 80 pg/ml for FKN.
　　Statistical analysis.　 Samples with values 
below the detection limit for the assay were regarded 
as negative and assigned a value of 0.  Data were 
expressed as the mean value ± SEM of the number of 
samples evaluated.  The statistical signiﬁ cance of dif-
ferences between 2 groups was determined by Mann-
Whitney U test or Wilcoxon’s signed rank test.  P 
values less than 0.05 were considered statistically 
signiﬁ cant.
Results
　　Levels of soluble FKN protein in serum and 
synovial ﬂ uid from RA patients and OA 
patients. We used ELISA to determine the levels 
of FKN in paired synovial ﬂ uid and serum samples 
obtained from 22 RA patients and 16 OA patients 
and 12 healthy controls (HC) (Fig.  1).  FKN levels in 
both the synovial ﬂ uid (34.32 ± 15.36 ng/ml) and 
serum (53.33 ± 19.63 ng/ml) of RA patients were sig-
niﬁ cantly greater than the levels in the synovial ﬂ uid 
(3.17 ± 2.48 ng/ml ; p ＜ 0.05) and serum 
(8.00 ± 4.46 ng/ml ; p ＜ 0.05) of OA patients and in 
the serum (0.56 ± 0.56 ng/ml) of HC.  In addition, 
the level of FKN did not signiﬁ cantly correlate with 
the CRP level (data not shown).
　　CX3CR1 expression in vascular endothelial 
cells and synovial lining macrophages in RA 
synovial tissue.　 To determine the expression of 
CX3CR1 at the site of inﬂ ammation,  synovial tissues 
from 5 patients with RA were analyzed by 2-color 
immunoﬂ uorescence labeling using anti-CD16 anti-
body and anti-CX3CR1 antibody.  Fig.  2 shows rep-
resentative staining patterns of CD16 and CX3CR1 
expression in the synovial tissue.  The CD16 and 
CX3CR1 double-positive cells were widely distrib-
uted throughout the synovial tissues,  including the 
lining and sublining layers ; while vascular endothe-
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Fig. 1　　Levels of soluble fractalkine (FKN) protein in both serum 
and synovial ﬂ uid from rheumatoid arthritis (RA) and osteoarthritis 
(OA) patients and healthy controls (HC).  Concentrations of FKN 
were measured in duplicate by the quantitative sandwich enzyme-
linked immunosorbent assay (ELISA).  n ＝ number of samples 
tested.  Values are the mean ± SEM.  ＊p ＜ 0.05 versus OA 
samples.
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lial cells were stained with CX3CR1 and lacked 
CD16 immunoreactivity.
　　Higher expression of CX3CR1 on CD14＋/
CD16＋ blood monocytes.　 The cell surface 
expression of CD14 and CD16 on peripheral blood 
monocytes from patients with RA and HC was deter-
mined by ﬂ ow cytometric analysis.  Fig.  3A shows 
the representative distribution of the CD14＋/CD16＋ 
or CD14＋/CD16－ monocyte subpopulations and their 
CX3CR1 expressions in the patients with RA and 
HC.  The population of CD14＋/CD16＋ blood mono-
cytes was larger in patients with RA (11.9 ± 5.8ｵ) 
than in the HC (9.2 ± 2.1ｵ),  conﬁ rming our previous 
observation [15].  We next compared the intensity of 
CX3CR1 on monocytes from patients with RA and 
HC.  The mean ﬂ uorescence intensity of CX3CR1 on 
CD14＋/CD16＋ monocytes was signiﬁ cantly greater 
than that on CD14＋/CD16－ monocytes both in 
patients with RA (p ＜ 0.05) and in HC (p ＜ 0.05). 
The mean ﬂ uorescence intensity of CX3CR1 on 
CD14＋/CD16＋ monocytes in patients with RA was 
not signiﬁ cantly diﬀ erent from that in HC (Fig.  3B).
　　IL-10-induced expression of CX3CR1 
mRNA in peripheral blood monocytes.　 We 
compared the expression of CX3CR1 on monocytes 
stimulated by TNFｸ,  IL-1ｹ,  IFNｺ,  LPS and IL-10. 
Peripheral blood monocytes were incubated for 3 h 
in culture medium with 10 ng/ml of TNFｸ,  IL-1ｹ, 
IFNｺ,  LPS or IL-10,  and the total RNAs were iso-
lated and subjected to quantitative real-time PCR. 
IL-10 induced 4.5-fold higher CX3CR1 mRNA 
expression (p ＜ 0.05),  while the treatment with LPS 
signiﬁ cantly reduced CX3CR1 mRNA expression 
(p ＜ 0.05) (Fig.  4).
　　TNFｸ- induced expression of FKN mRNA 
in synovial ﬁ broblasts.　 We next compared the 
expression of FKN on ﬁ broblasts in the presence of 
TNFｸ,  IL-1ｹ,  IFNｺ and LPS.  Synovial ﬁ broblasts 
were incubated for 3 h in culture medium with 10 ng/
ml of TNFｸ,  IL-1ｹ,  IFNｺ,  or LPS,  and total RNA 
was isolated to determine the expression of FKN by 
quantitative real-time PCR.  Treatment with TNFｸ 
signiﬁ cantly increased FKN mRNA expression 
(p ＜ 0.05) (Fig.  5).
　　Synovial ﬁ broblasts synthesized FKN in 
response to the stimulation with TNFｸ.　 We 
next determined the concentration of soluble and 
membrane-bound FKN in the supernatant and cell 
lysates from the synovial ﬁ broblasts in the presence 
of various cytokines.  We detected the induction of 
soluble FKN in the supernatant from TNFｸ- and 
IL-1ｹ-stimulated ﬁ broblasts,  although IFNｺ and 
LPS did not aﬀ ect the release of soluble FKN 
(p ＜ 0.05) (Fig.  6A).  Similarly,  the amount of mem-
brane-bound FKN in synovial ﬁ broblasts was signiﬁ -
cantly up-regulated in the presence of TNFｸ 
(p ＜ 0.05) (Fig.  6B).
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Fig. 2　　Expression of CD16 and CX3CR1 in synovial tissues of rheumatoid arthritis (RA) patients.  Synovial tissue sections from RA 
patients were stained with anti-CX3CR1 Ab and anti-CD16 Ab followed by incubation with isotype-speciﬁ c Texas red- and FITC-
conjugated secondary Abs (CX3CR1,  red ; CD16,  green).
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　　Eﬀ ects of FKN on IL-1ｹ and IL-6 produc-
tion by monocytes.　 It has been reported that 
immobilized and membrane-bound FKN markedly 
induced IFNｺ production by NK cells [21]. 
However,  it remains to be determined whether FKN 
induces cytokine production by monocytes. 
Therefore,  we examined whether soluble FKN 
induced production of cytokines by monocytes. 
Activated monocytes that had been pretreated with 
DBcAMP were stimulated with recombinant human 
FKN.  The culture supernatants were harvested and 
subjected to ELISA to determine their concentra-
tions of IL-1ｹ and IL-6.  The addition of recombinant 
FKN increased the production of both IL-1ｹ and 
IL-6 by monocytes in a dose-dependent manner 
(p ＜ 0.05) (Fig.  7A and B).
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Fig. 3　　Expression of CX3CR1 on CD14＋/CD16＋ blood monocytes.  (A) Peripheral blood mononuclear cells from patients with RA and 
healthy controls (HC) were stained with FITC-conjugated anti-CX3CR1 mAb,  phycoerythrin (PE)-conjugated anti-CD14 mAb,  and 
phycoerythrin-cyanin 5.1 (PC5) -conjugated anti-CD16 mAb.  Flow cytometric analysis of the cell surface expression of CD14,  CD16, 
and CX3CR1 was performed by gating on monocytes according to size,  granularity,  and CD16 expression.  Two subsets of monocytes 
were identiﬁ ed : CD14＋/CD16＋ and CD14＋/CD16－.  The CD14＋/CD16＋ monocytes in the upper right panel account for 8.8% and 13.8% 
of all CD14-expressing cells in the representative HC and RA patient,  respectively.  Representative histographic patterns of CX3CR1 
expression on CD14＋/CD16＋ and CD14＋/CD16－ blood monocytes from an HC and RA patient are shown.  (B) The intensity of CX3CR1 
on CD14＋/CD16＋ blood monocytes was expressed as the ratio of the mean ﬂ uorescence intensity (MFI) of staining with anti-CX3CR1 to 
that of staining with the control antibody.  Values are the mean ± SEM.  ＊p ＜ 0.05 versus CD14＋/CD16－ blood monocytes.
6
Acta Medica Okayama, Vol. 61 [2007], Iss. 2, Art. 6
http://escholarship.lib.okayama-u.ac.jp/amo/vol61/iss2/6
Discussion
　　The CD14＋/CD16＋ monocytes express higher 
levels of class II MHC molecules,  adhesion mole-
cules,  and chemokine receptors and are able to more 
eﬃ  ciently produce proinﬂ ammatory cytokines,  as 
compared with the classic CD14＋＋/CD16－ mono-
cytes [17].  Thus,  this minor population is consid-
ered to comprise proinﬂ ammatory monocytes that can 
rapidly migrate to the site of inﬂ ammation and read-
ily diﬀ erentiate into tissue macrophages.  We previ-
ously demonstrated that CD14＋/CD16＋ blood mono-
cytes are increased in active RA in association with 
a cytokine spillover from joints with inﬂ ammation 
[15].  Moreover,  CD14＋/CD16＋ monocytes express 
high levels of Toll-like receptor 2 and are able to 
eﬃ  ciently produce proinﬂ ammatory cytokines such as 
TNFｸ [22].  In agreement with previous studies [23, 
24],  we here found that CD16＋ monocytes expressed 
CX3CR1 more prominently than CD16－ monocytes, 
both in RA patients and healthy controls.
　　IL-10 plays a predominant role in limiting immune 
and inﬂ ammatory responses by regulating the func-
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Fig. 5　　Expression of FKN mRNA in cultured synovial ﬁ broblasts. 
Synovial ﬁ broblasts from RA patients were stimulated in fresh 10% 
FCS/culture medium with 10 ng/ml of TNFｸ,  IL-1ｹ,  IFNｺ and 
LPS.  Total RNA was isolated from synovial ﬁ broblasts after 3 h of 
culture.  FKN mRNA was detected by RT-PCR.  Levels of FKN 
mRNA were normalized relative to β-actin expression.  Values are 
the mean ± SEM.  ＊p ＜ 0.05 versus the control.
＊: p＜0.05
n＝8
ﾝ IL-1ｹTNFｸ LPSIFNｺ
10
9
8
7
6
5
4
3
2
1
0
So
lu
bl
e
FK
N
 p
ro
du
ct
io
n 
(n
g/
m
l)
A
＊: p＜0.05
n＝8
ﾝ IL-1ｹTNFｸ LPSIFNｺ
18
16
14
12
10
8
6
4
2
0
m
em
br
an
e-
bo
un
d
FK
N
 p
ro
du
ct
io
n 
(n
g/
m
l)
B
Fig. 6　　Induction of soluble FKN in the culture supernatant and 
membrane-bound FKN in the cell lysate of synovial ﬁ broblasts. 
Synovial ﬁ broblasts from RA patients were stimulated with 10 ng/
ml of TNFｸ,  IL-1ｹ,  IFNｺ,  and LPS for 24 h.  Then,  culture 
supernatants (A) and cell lysates that were treated with passive 
lysis buﬀ er (B) were collected and measured for soluble and 
membrane-anchored FKN concentrations by ELISA.  Values are 
the mean ± SEM.  ＊p ＜ 0.05 versus the control.
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Fig. 4　　Expression of CX3CR1 mRNA in cultured monocytes. 
Monocyte suspensions from HC were stimulated in fresh 10% 
FCS/culture medium with 10 ng/ml of TNFｸ,  IL-1ｹ,  IFNｺ,  LPS 
and IL-10.  Total RNA was isolated from monocytes after 3 h of 
culture.  CX3CR1 mRNA was detected by RT-PCR.  Levels of 
CX3CR1 mRNA were normalized relative to β-actin expression. 
Values are the mean ± SEM.  ＊p ＜ 0.05 versus the control.
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tion of both macrophages and Th1 cells [25].  IL-10 
in combination with M-CSF and IL-4 contributes to 
the development of the rare population of CD14＋/
CD16＋ cells derived from human monocytes [26]. 
Incubation of a microglial cell line with LPS down-
regulated CX3CR1 mRNA expression to almost 
undetectable levels.  However,  in the presence of 
IL-10,  LPS did not reduce CX3CR1 transcript pro-
duction [27].  We conﬁ rmed by RT-PCR that IL-10 
induced high levels of CX3CR1 mRNA expression on 
monocytes.  These ﬁ ndings suggest that IL-10 induces 
the synchronous expression of both CD16 and 
CX3CR1 on the cell surface of monocytes. 
Consequently,  the CD16＋ monocyte subpopulation 
revealed prominent expression of CX3CR1.  The 
ligand for CX3CR1,  FKN,  is also regulated by vari-
ous cytokines,  and it has been reported that FKN is 
up-regulated by treatment with TNFｸ,  IL-1ｹ,  or 
IFNｺ.  In the present study,  FKN was prominently 
induced in synovial ﬁ broblasts by TNFｸ,  and neither 
IL-1ｹ nor IFNｺ altered the FKN levels.  Since 
Fraticelli et al.  [28] reported that FKN expression 
was induced in human umbilical vein endothelial cells 
(HUVECs) by 24 h-incubation of IFNｺ,  the 3-h incu-
bation time used in the present study may not have 
been suﬃ  cient for the induction of FKN in synovial 
cells.
　　Another important ﬁ nding of our study is that 
high levels of soluble FKN were produced in the 
synovial ﬂ uid and detected in the sera of RA patients. 
Moreover,  we conﬁ rmed by two-color immunoﬂ uores-
cence staining that high levels of CX3CR1 were 
expressed in CD16＋ monocytes localized to the lining 
and sublining layer.  These results suggest that FKN 
may preferentially promote the migration of CD16＋ 
monocytes into the synovial tissues,  and such recruit-
ment of the proinﬂ ammatory monocyte subset may 
contribute to the tissue injury and destruction of the 
joints [24].  FKN stimulation of cultured synovial 
ﬁ broblasts has been shown to result in a marked 
upregulation of matrix metalloproteinase-2 produc-
tion [29].  In contrast,  LPS-induced TNFｸ secre-
tion by monocytes [30] and microglia [31,  32] were 
inhibited by FKN.  These results suggest that FKN 
modulates immune responses to induce or inhibit the 
production of various cytokines.  To assess the 
involvement of FKN in inﬂ ammatory processes,  we 
examined the eﬀ ect of soluble FKN on cytokine pro-
duction by monocytes.  We found that soluble FKN 
markedly induced IL-1ｹ and IL-6 production by 
monocytes in a dose-dependent manner.
　　The mechanisms underlying the cytokine induction 
are unknown ; however,  Chandrasekar et al.  [33] 
have shown that FKN induced its own expression in 
aortic smooth muscle cells via heterotrimeric 
Gi-proteins,  phosphoinositide 3-kinase (PI3-kinase), 
phosphoinositide-dependent kinase1 (PDK1),  Akt, 
NF-κB-inducing kinase (NIK),  inhibitoryκB kinase 
(IKK) and NF-κB.  In another study,  FKN was 
shown to activate NF-κB and p53,  resulting in IL-8 
and FKN mRNA expression on intestinal epithelial 
cells [34].  These ﬁ ndings may suggest a role for 
FKN expressed on synovial ﬁ broblasts through the 
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Fig. 7　　Eﬀ ects of FKN on IL-1ｹ and IL-6 production by cultured 
monocytes.  Monocytes from HC were treated for 3 h with 
DBcAMP (10 mM) prior to the addition of various concentrations of 
recombinant human FKN.  The culture supernatants were 
harvested after 36 h of FKN treatment,  and then IL-1ｹ (A) and 
IL-6 (B) concentrations were measured by ELISA.  Values are the 
mean ± SEM.
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stimulation of IL-1ｹ and IL-6 production by mono-
cytes as well as FKN production by ﬁ broblasts. 
Such soluble FKN-mediated paracrine and autocrine 
ampliﬁ cation loops would further activate the mono-
cytes and lead to prominent cytokine production in 
the synovium of RA patients.
　　In summary,  soluble FKN levels were signiﬁ -
cantly elevated in synovial ﬂ uid and sera,  which 
induced the production of cytokines,  such as IL-1ｹ 
and IL-6,  by monocytes in RA patients.  The acti-
vated monocytes secreted IL-10 and up-regulated 
CX3CR1 and CD16＋ expression in an autocrine fash-
ion.  Interactions of FKN and CX3CR1 via chemotac-
tic and adhesive processes might contribute to the 
accumulation of CD16＋ monocytes expressing 
CX3CR1 at the synovial tissue of RA patients and 
continuation of inﬂ ammation at the site.  Recently,  it 
has been reported that inhibition of FKN ameliorated 
collagen-induced arthritis in mice,  most likely by 
suppressing inﬂ ammatory cell migration into the RA 
synovium [35].  Thus,  FKN may become a new tar-
get molecule for the treatment of RA in the future.
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